ARCALIS, Inc.
PrivateLast Round
Strategic
Nov 14, 2024
Total Funding Raised
$274.11M
Company Overview
ARCALIS, Inc. operates in Healthcare & Life Sciences and is based in Japan. Its latest recorded funding round was a Strategic round in November 2024.
ARCALIS, Inc. is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) specializing in mRNA vaccines and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARCALIS, Inc. Comparables
Compare ARCALIS, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RiboPro | 84% | |
| Vernal Biosciences | 82% | |
| Anemocyte | 80% |
For institutional investors. Book with your work email.
ARCALIS, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 14, 2024 | ||||
| Debt | Jan 31, 2024 | ||||
| Grant | Oct 4, 2023 | ||||
| Debt | Oct 31, 2022 |
For institutional investors. Book with your work email.
ARCALIS, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Debt |
| Joyo Bank, Ltd. | Debt |
| Ministry of Economy, Trade and Industry | Grant |
| Aozora Bank | Debt |
| Sumitomo Mitsui Banking Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 128% MoM, reaching 5.8K.
- Oct 29, 2024
Monthly visitors increased 188% MoM, reaching 7.5K.
For institutional investors. Book with your work email.
ARCALIS, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ARCALIS, Inc.'s valuation, stock price, and market status.
Is ARCALIS, Inc. a public or private company?
ARCALIS, Inc. is a private company.
What is the current stock price of ARCALIS, Inc.?
ARCALIS, Inc. is a private company, so its shares have no public market price. Caplight tracks ARCALIS, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ARCALIS, Inc. worth (valuation)?
Valuation information for ARCALIS, Inc. is not publicly available.
Can I buy ARCALIS, Inc. stock?
ARCALIS, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ARCALIS, Inc.'s last funding round?
ARCALIS, Inc.'s most recent funding round was Strategic on November 14, 2024.
Who are the main investors in ARCALIS, Inc.?
Key investors in ARCALIS, Inc. include Sumitomo Mitsui Trust Bank, Joyo Bank, Ltd., Ministry of Economy, Trade and Industry, Aozora Bank, Sumitomo Mitsui Banking Corporation.
Will ARCALIS, Inc. IPO soon?
No public IPO plans have been announced for ARCALIS, Inc..
How can I track ARCALIS, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ARCALIS, Inc.'s shares on secondary markets.